↓ Skip to main content

An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary…

Overview of attention for article published in BMC Cancer, July 2018
Altmetric Badge

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
52 Mendeley